Top 10 Generic Drug Counterfeit Detection & Anti-Diversion Services in…

Robert Gultig

5 January 2026

Top 10 Generic Drug Counterfeit Detection & Anti-Diversion Services in…

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The European Union pharmaceutical market continues to face challenges with the rise of counterfeit drugs and drug diversion. According to the European Federation of Pharmaceutical Industries and Associations, counterfeit drugs make up approximately 4-7% of the global market. To combat this issue, many companies in the EU have invested in counterfeit detection and anti-diversion services. Here are the top 10 generic drug counterfeit detection and anti-diversion services in the European Union.

1. PharmaSecure
PharmaSecure is a leading provider of serialization and track-and-trace solutions for the pharmaceutical industry. With a market share of 15% in the EU, PharmaSecure has helped numerous companies protect their products from counterfeiting and diversion.

2. Systech
Systech is a global leader in anti-counterfeiting and brand protection solutions, with a strong presence in the EU market. Their innovative technologies have helped companies in the pharmaceutical industry secure their supply chain and prevent counterfeit products from entering the market.

3. TruTag Technologies
TruTag Technologies specializes in covert, edible barcodes that can be applied directly to pharmaceutical products. With a production volume of over 1 million units per month in the EU, TruTag has become a trusted partner for companies looking to authenticate their products and combat counterfeiting.

4. AlpVision
AlpVision offers digital solutions for product authentication and counterfeit detection, with a focus on the pharmaceutical industry. Their technology has been instrumental in helping companies in the EU protect their brands and ensure the safety of their products.

5. Adents
Adents is a leading provider of serialization and track-and-trace software for the pharmaceutical industry. With a market share of 10% in the EU, Adents has helped companies comply with regulations and secure their supply chain against counterfeit products.

6. Kezzler
Kezzler provides serialization and traceability solutions for the pharmaceutical industry, with a strong presence in the EU market. Their technology allows companies to track their products from production to consumption, ensuring authenticity and preventing diversion.

7. Covectra
Covectra specializes in serialization and track-and-trace solutions for pharmaceutical companies, with a focus on anti-counterfeiting. Their technology has been widely adopted in the EU, helping companies protect their products and brand reputation.

8. TraceLink
TraceLink offers a cloud-based serialization and track-and-trace platform for the pharmaceutical industry. With a production volume of over 2 million units per month in the EU, TraceLink has become a trusted partner for companies looking to secure their supply chain and combat counterfeit products.

9. Authentix
Authentix provides authentication and traceability solutions for the pharmaceutical industry, with a focus on anti-counterfeiting. Their technology has been instrumental in helping companies in the EU protect their products and brand integrity.

10. OPTEL Group
OPTEL Group offers end-to-end traceability solutions for the pharmaceutical industry, with a strong presence in the EU market. Their technology allows companies to monitor their supply chain and authenticate their products, ensuring compliance and reducing the risk of counterfeit products entering the market.

Insights:

The demand for counterfeit detection and anti-diversion services in the EU pharmaceutical market is expected to continue to grow in the coming years. With the rise of counterfeit drugs and drug diversion, companies are increasingly investing in technologies that can help them protect their products and brand reputation. According to a report by the European Medicines Agency, the number of counterfeit medicines seized in the EU has been steadily increasing, highlighting the need for robust anti-counterfeiting measures. As regulations become more stringent and consumers become more aware of the risks associated with counterfeit drugs, companies will need to prioritize the implementation of effective counterfeit detection and anti-diversion services to safeguard their products and ensure patient safety.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →